Navigation Links
NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople

San Diego CA (PRWEB) February 09, 2013

Resource4thePeople announced today that as the number of lawsuits filed by victims who claim blood-clotting problems as a result of their use of the NuvaRing contraceptive has climbed to more than 1,000* it is continuing to provide referrals for victims of these side effects to lawyers offering free consultations.

These consultations can provide legal options to women who may have suffered health problems from blood clotting, such as deep vein thrombosis, pulmonary embolisms, strokes and heart attacks. Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.

“This announcement is being made in case there is any confusion among women who might have suffered serious health problems similar to those alleged in what is now a large, consolidated federal court proceeding,” said Resource4thePeople.

“The situation that now exists, according to the court record in over 1,000 such cases before a federal judge in Missouri, is that the first trials are not scheduled to begin until the middle of this year and victims who are not aware of where this litigation stands have the right to know that they still have time to seek free advice about their legal rights to possible compensation.”

This reference is to the federal multidistrict litigation that is being overseen by U.S. District Judge Rodney W. Sippel in the Eastern District of Missouri.* Judge Sippel originally had scheduled the first trial for May but has rescheduled it for July.

Multidistrict litigations are designated by a special panel of federal judges in cases in which large numbers of plaintiffs file similar allegations against common defendants in the interest of judicial efficiency and to avoid duplicative and conflicting legal proceedings.

In such litigations the judge oversees pre-trial evidence-gathering and legal requirements, schedules bellwether cases to allow both plaintiffs and defendants to weigh the strengths and weaknesses of their cases and presides over mediations and settlement discussions.

The judge is also asked to rule on whether such cases should be certified as class-action cases, in which a large pool of plaintiffs are given the choice of whether to remain in the litigation or proceed with their individual case outside of the outcome of the class action.

Resource4thePeople is also providing an information bank in which recent developments in the NuvaRing litigation and information about the popular IUD from medical researchers, news media and the Food and Drug Administration are posted at:

The allegations cited in this multidistrict litigation claim that NuvaRing, described by company officials as the first hormonal IUD, puts women at risk of suffering blood clots that can lead to life-threatening health problems because of the hormone mixture that prevents pregnancies.

The NuvaRing was approved by the Food and Drug Administration in 2001 after being created by Organon BioSciences as a flexible IUD, or ring, hence the name. The IUD releases a low dose of etonogestrel and estrogen over three weeks, providing women the flexibility of a monthly contraceptive.

This flexibility was one of the marketing factors that made the NuvaRing what was described as an easy and healthy contraceptive choice to women who were not satisfied with the side effects caused by birth control pills and the necessity of taking them each day.

However, by 2011 the FDA released the findings of government research that put women who used the NuvaRing or other IUDs with a similar mixture of hormones at a 56 percent higher risk of suffering blood clotting that led to deep vein thrombosis and pulmonary embolisms than women on birth control pills.**

Resource4thePeople is committed to informing women about the risks they may face in their choices of contraception and to providing them data that ensures the protection of their health and that of any infants they may give birth to who may be exposed to side effects from contraceptive devices.

In announcing that free legal consultations are still being offered to women who may have suffered serious side effects from the use of the NuvaRing, Resource4thePeople notes that NuvaRing has now posted warnings about the increased risks of suffering blood clots on the company’s web site under the heading of “IMPORTANT SAFETY INFORMATION.***

Resource4thePeople recommends that women choosing a type of birth control review the company’s warning:

  •     The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing use than with the use of certain birth control pills.
  •     NuvaRing is not for women with certain cancers or those who may be pregnant.
  •     NuvaRing does not protect against HIV infection and other sexually transmitted diseases.
  •     The most common side effects reported by NuvaRing users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea.


  • In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, U.S. District Court, Eastern District of Missouri

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
2. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
3. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
4. U-M sibling study discovers genetic region linked to control of key blood-clotting protein
5. Lung Cancer Asbestos Victims Center Now Urges Non Smokers To Call Them If They Now Have Lung Cancer And Were Exposed To Asbestos On The Job-Possible Major Compensation
6. Lung Cancer Asbestos Victims Center Urges Families Of Lung Cancer Victims To Ask The Victim If They Were Exposed To Asbesto On the Job And To Call Them If They Say-Yes
7. Mesothelioma Victims Center Now Fears Most US Nany Veterans Diagnosed With Mesothelioma Get Shortchanged So They Provide The Names Of The Best Mesothelioma Law Firms
8. Lung Cancer Asbestos Victims Center Urges All Individuals Diagnosed With Lung Cancer Who Had On The Job Exposure To Asbestos To Call Them About Financial Compensation
9. US Drug Watchdog Now Urges All Victims Of The Transvaginal Mesh Product Failure With Erosion To Call Them For The Names Of National Caliber Attorneys--Who are all Women
10. US Drug Watchdog Now Expands Their All Metal Hip Implant Initiative By Inviting The Top Personal Injury Law Firms In All States To Help Them Get More Victims Indentified
11. Mesothelioma Victims Center Now Offers Names And Contacts Of The Best Mesothelioma Law Firms For Diagnosed Former Shipyard Workers In CA, WA, VA and Nationwide
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
(Date:11/24/2015)... New York , 24. November 2015 ... des Avery Breathing Pacemaker Systems, ist erfreut, ... als Clinical Consultant bekannt geben zu können. ...   --> Foto ... Stockholm (Schweden). Von 1984-1986 war ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
Breaking Medicine Technology: